It was a year 5 market day at Newport Lakes Primary School that sparked young Brandon Winkworth’s determination to raise ...
Biohaven Ltd. (NYSE: BHVN) (Biohaven) on Saturday presented preclinical data for BHV-1420 in an oral presentation at the ...
Idiopathic membranous nephropathy (IMN) is frequently driven by autoantibodies targeting phospholipase A2 receptor 1 (PLA2R), resulting in immune-mediated glomerular injury and proteinuria.
Biohaven Ltd. (NYSE: BHVN) (Biohaven) on Saturday presented preclinical data for BHV-1420 in an oral presentation at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado.
You wake up one morning, open your stock chart, and find that a stock you hold has jumped by 50%. Or, without any warning, it ...
Biohaven Ltd (NYSE:BHVN) soared up to 25.02 percent on Thursday, closing at $14.69 apiece, as investors gobbled up shares ...
Biohaven jumps after FDA accepts Vyglyxia's NDA resubmission, but pipeline focus and approval risks cloud the outlook. Read ...
Revenue for SMCP, parent company of high-end labels Sandro, Maje, Claudie Pierlot and Fursac, was virtually flat in Q3, and ...
M Sales at €888m, remaining broadly stable on an organic 1 basis (-0.2%) compared to 2025 (€896m) Organic sales growth in America (+8.6%) and in the EMEA region (+5.5%); sales stabilization in ...
The transaction grants Ono exclusive rights for candidates BHV-1300, BHV-1310, and BHV-1320 across Taiwan, South Korea, and Japan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results